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Simple Measurement of Gluconeogenesis by Direct 2H
NMR Analysis of Menthol Glucuronide Enrichment
from 2H2O
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The contribution of gluconeogenesis to fasting glucose produc-
tion was determined by a simple measurement of urinary men-
thol glucuronide (MG) 2H enrichment from 2H2O. Following in-
gestion of 2H2O (0.5% body water) during an overnight fast and
a pharmacological dose (400 mg) of a commercial peppermint
oil preparation the next morning, 364 mol MG was quantita-
tively recovered from a 2-h urine collection by ether extraction
and a 125 mol portion was directly analyzed by 2H NMR. The
glucuronide 2H-signals were fully resolved and their relative
intensities matched those of the monoacetone glucose deriva-
tive. The pharmacokinetics and yields of urinary MG after in-
gestion of 400 mg peppermint oil as either gelatin or enteric-
coated capsules 1 h before breakfast were quantified in five
healthy subjects. Gelatin capsules yielded 197 81 mol of MG
from the initial 2-h urine collection while enteric-coated cap-
sules gave 238  84 mol MG from the 2- to 4-h urine
collection. Magn Reson Med 54:429–434, 2005. © 2005 Wiley-
Liss, Inc.
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Deuterated water is widely considered a practical tracer of
endogenous glucose production in humans. After inges-
tion, the deuterium distributes rapidly into bulk body
water and is incorporated into numerous metabolites in-
cluding hepatic glucose-6-phosphate (G6P). During fast-
ing, the ratio of 2H enrichment in positions 5 and 2 of G6P
reflects the relative contribution of glycogenolysis and glu-
coneogenesis to hepatic G6P synthesis (1). The bulk of
fasting plasma glucose is derived from hepatic G6P; there-
fore, both metabolites share a common 2H enrichment
pattern under isotopic steady-state conditions. On this
basis, the contribution of gluconeogenesis to fasting glu-
cose production can be obtained by quantifying 2H enrich-
ment in positions 5 and 2 of plasma glucose (1–3). This can
be achieved by a very sensitive but labor-intensive deho-
mologation and mass-spectrometry procedure (1,4), or al-
ternatively, by a less sensitive but more convenient 2H
NMR analysis of a monoacetone glucose (MAG) derivative
(5–7). MAG is easily prepared from plasma glucose and
has fully resolved 2H NMR signals for all hydrogens at-
tached to the hexose skeleton. Quantification of the 5:2
deuterium enrichment ratio from the relative areas of the
2H NMR signals of hydrogen 5 and 2 is simple and pro-
vides estimates of gluconeogenesis that are consistent with
the MS procedure (8). Due to rapid exchange between
hepatic G6P and glucose-1-phosphate (G1P), the 5:2 deu-
terium enrichment ratio of G6P is also preserved in the
hexose moieties of G1P, UDP-glucose, and glucuronide.
Preliminary studies suggest that the 5:2 deuterium enrich-
ment ratio of urinary paracetamol glucuronide is equal to
that of plasma glucose under fasting conditions (9). The
high abundance of urinary paracetamol glucuronide al-
lows NMR collection times to be reduced by a factor of 10
or more in comparison to analysis of plasma glucose (9).
However, paracetamol glucuronide has poorly dispersed
hydrogen NMR signals; hence, it must be derivatized to
MAG for 2H NMR analysis. MAG preparation from urinary
glucuronide is considerably more labor intensive than its
preparation from plasma glucose (9) and is a significant
obstacle for the routine analysis of a large number of urine
samples. Therefore, a direct analysis of urinary glucuro-
nide 2H enrichment with minimal sample processing
would be highly desirable for quantifying gluconeogenesis
from 2H2O. Menthol glucuronide (MG) is a suitable metab-
olite for such an analysis for the following reasons. First,
the chemical shifts of its glucuronide hydrogens are highly
dispersed, providing complete resolution of 2H NMR sig-
nals at fields of 11.75 T or higher. Second, menthol gluc-
uronide can be rapidly isolated from urine either as a
crude ammonium salt or by simple ether extraction (10).
Third, recent studies suggest that 100 mol1 or more of
urinary menthol glucuronide can be recovered from hu-
mans following the consumption of safe quantities of men-
thol. After ingestion of 100 mg (640 mol) menthol in
gelatin capsules, about 50% was recovered as urinary
menthol glucuronide with an elimination half-life of 1 h
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1Given favorable 2H signal linewidths, this quantity of glucuronide enriched
0.5% 2H would allow 2H NMR spectra with high signal to noise ratios (25:1) to
be collected in 3 h or less with a conventional 5-mm broadband probe
operating at 11.75 T.
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(11). No adverse effects were reported following menthol
administration and subjects were unable to distinguish
between ingestion of menthol and placebo capsules. Sim-
ilar quantities of menthol can also be safely ingested in the
form of peppermint oil, which contains 50–70% menthol
and is used as a nonprescription medication to relieve
digestive ailments such as irritable bowel syndrome. Dos-
ages of 200–400 mg peppermint oil, administered as gel-
atin capsules, are considered safe. These capsules are
available in both gelatin and enteric-coated formulations.
Enteric capsules deliver peppermint oil into the small
intestine, thereby eliminating the possibility of esophageal
discomfort from gastric reflux of menthol. In this report,
we demonstrate that the fractional contribution of glu-
coneogenesis to hepatic glucose production can be quan-
tified in a very simple manner by direct 2H NMR spectros-
copy of urinary menthol glucuronide following ingestion
of 2H2O and peppermint oil capsules.
METHODS
Human Studies
Five healthy and nonobese young adults (two females and
three males) participated in the studies. All subjects pro-
vided informed consent for the peppermint oil and 2H2O
ingestion studies. One hour before a light breakfast, sub-
jects ingested two gelatin capsules each containing 200 mg
peppermint oil suspended in sunflower seed oil (Obbek-
jaers, Carisan Alps, Herlev, Denmark). Urine was collected
every 2 h until 8 h after ingestion. Subjects repeated the
same procedure at least 4 weeks later with enteric-coated
gelatin peppermint oil capsules. To obtain menthol glu-
curonide enriched with 2H in the setting of Landau’s 2H2O
measurement of gluconeogenesis, one of the subjects par-
ticipated in an additional study. He began fasting at 21:00
and was given 2H2O to 0.5% body water enrichment.
This was taken as two loading doses of 300 mL 35%
2H2O taken at 01:00 and 03:00 the following day. At 07:00
the subject ingested two enteric-coated peppermint oil
capsules and urine was collected every 2 h until 13:00. No
food was ingested during this time.
Sample Processing
Commercial ammonium menthol glucuronide (Sigma-Al-
drich) was converted to the acid by passage of 1 mL of 0.1 M
solution through 1 mL of Dowex-50-H-200–400 mesh
ion-exchange resin in a Pasteur pipette followed by 5 mL
water. Thewater was evaporated and thementhol glucuronic
acid was dissolved in 0.6 mL of dry acetonitrile-d3. Urine
samples were concentrated about 10- to 20-fold to final vol-
umes of 15–30 mL by rotary evaporation. The pH was ad-
justed to 7.0 with NaOH and an aliquot was removed for
quantification of menthol glucuronide by 1H NMR. The con-
centrated urine was then acidified to pH 1.5 with concen-
trated HCl. Any precipitate formed was removed by centrif-
ugation and a saturating amount of NaCl was added to the
supernatant. The solution was extracted 4–6 times with an
equal volume of ether until the ether fraction was devoid of
color. The ether fractions were pooled and weighed and an
aliquot representing1% of the total was reserved for quan-
tification of menthol glucuronide by 1H NMR. For quantifi-
cation of 2H enrichment by 2H NMR, the ether extract was
thoroughly dried by rotary evaporation and the residue dis-
solved in 1–2 mL dry acetonitrile. The sample was heated to
75°C and incubated for 5–6 h. Any insoluble material
that was formed by this treatment was removed by cen-
trifugation. An aliquot of the clear supernatant contain-
ing 125 mol of the glucuronide was evaporated to
dryness and resuspended in 0.6 mL dry acetonitrile for
2H NMR analysis.
Derivatization of Menthol Glucuronide to Monoacetone
Glucose
Thementhol glucuronide ether extract was dissolved in 5mL
of water and 2 mL of Dowex-50-H ion exchange resin was
added. The mixture was boiled for 8 h resulting in the com-
plete hydrolysis of menthol glucuronide to menthol and glu-
curonic acid. The ion-exchange resin was separated from the
mixture by filtration and washed with 5 mL water. The wash
was combined with the filtrate and evaporated to dryness at
40°C. The residuewas further dried over molecular sieves for
48 h resulting in the conversion of glucuronic acid to lactone.
The lactone was converted to its monoacetone derivative by
stirring for 24 h with 5 mL of anhydrous acetone and 0.3 g of
anhydrous Dowex-50-H-200-mesh ion-exchange resin. The
ion-exchange resin was then removed by filtration, the pH
was adjusted to 4–5 with 0.5 M Na2CO3, and the solution
was evaporated to dryness at room temperature. Monoac-
etone glucuronic lactone was extracted from the residuewith
1–2 mL acetonitrile. On evaporation of acetonitrile, the
monoacetone glucuronic lactone was reduced in aqueous
solutionwith sodium borohydride toMAG (12). Excess boro-
hydride was destroyed by passage of the solution through a
2- to 3-mL column of Dowex-50-H ion exchange resin.
Under these conditions, acid-catalyzed hydrolysis of MAG to
glucose was minimal. The elutate was evaporated to dryness
and then dissolved in 10mLmethanol and evaporated again.
Methanol addition and evaporation was repeated three more
times to completely remove boric acid as the volatile methyl
borate. The residue was dissolved in a small quantity of
water and the pH was adjusted to 12 by the addition of 2 M
Na2CO3. The basic solution was evaporated and MAG was
extracted with two 1- to 2-mL portions of boiling ethyl ace-
tate. For NMR spectroscopy, the ethyl acetate was evaporated
and the residue resuspended in 90% acetonitrile/10% water
(5). Yields of MAG from menthol glucuronide were about
20%.
NMR Spectroscopy
All 1H and 2H NMR spectra were obtained with a Varian
Unity 11.75-T system equipped with a 5-mm broadband
probe. Menthol glucuronide 1H chemical shifts were as-
signed from 1H COSY spectra of commercial menthol gluc-
uronide and urine ether extracts. For quantification of
urinary menthol glucuronide, an aliquot of the concen-
trated urine was assayed for menthol glucuronide by ad-
dition of 25 L of a 0.4 M sodium formate solution and 0.3
mL 99% 2H2O. The sample volume was then adjusted to
0.6 mL with water and fully relaxed 1H NMR spectra were
obtained at 25°C with presaturation of the water signal.
The upfield methyl 1H signals of the menthol moiety of
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menthol glucuronide were quantified relative to that of
formate signal. Menthol glucuronide from aliquots of ether
extracts was quantified in the same manner after evapora-
tion of ether, resuspension of the residue in 0.3 mL water,
and adjustment of the solution pH to 7.0 with 1 M NaOH.
Proton-decoupled 2H NMR spectra were obtained in the
unlocked mode at a temperature of 75°C with a 90° pulse,
a 1.5-sec acquisition time, and no interpulse delay. Spectra
of monoacetone glucose derived from the menthol gluc-
uronide were obtained with the same equipment and ac-
quisition parameters at a temperature of 50°C (6,13). Ab-
solute 2H enrichment of the monoacetone glucose hydro-
gens was quantified as described (13) except that
dimethylformamide-d7 was used as a standard instead of
formate-d. Thus, the 2H intensities of the three dimethyl-
formamide signals were compared with those of mono-
acetone glucose after correction for partial saturation ef-
fects. Deconvolution and quantification of 1H and 2H NMR
signals was performed with the curve-fitting routine sup-
plied with the NUTS PC-based NMR spectral analysis
program (Acorn NMR, Inc., Fremont, CA, USA).
RESULTS
Recovery of Urinary Menthol Glucuronide from Peppermint
Oil
Ingestion of 400 mg peppermint oil in plain gelatin cap-
sules before a light breakfast meal resulted in the rapid
appearance of urinary menthol glucuronide with the great-
est amount being recovered from the first 2 h of urine
collection (Fig. 1). With enteric-coated capsules, the ap-
pearance of urinary menthol glucuronide was systemati-
cally delayed, with the highest quantity being recovered
from urine collected 2–4 h after peppermint oil ingestion.
This delay presumably reflects the time taken for the pep-
permint oil capsule to reach the small intestine before its
dissolution. The peak yields of urinary menthol glucuro-
nide were similar for both capsules, with200 mol being
harvested from a 2-h urine collection. Between 70 and
90% of urinary MG was recovered by simple ether extrac-
tion (data not shown) resulting in 140–180 mol of glu-
curonide being available for direct 2H NMR analysis. In the
single fasted study where 2H2O was ingested, enteric-
coated peppermint oil was given and a somewhat higher
yield of MG (364 mol) was recovered from the 2- to 4-h
urine collection. This may reflect a more efficient absorp-
tion of menthol in the absence of ingested food.
Positional 2H-Enrichment Analysis of Menthol Glucuronide
by 2H NMR
The five hydrogen NMR signals from the glucuronide moi-
ety of menthol glucuronide are highly dispersed (Fig. 2).
FIG. 1. Quantity of menthol glucuronide from urine samples taken
every 2 h after ingestion of plain gelatin capsules (open circles) and
enteric-coated gelatin capsules (closed circles). Each datum repre-
sents the mean quantity from five individuals and its error bar
represents the SD.
FIG. 2. 1H and 2H NMR spectra of a portion of an
ether extract obtained from urine collected after
ingestion of peppermint oil and 2H2O. The sample
contained 125 mol menthol glucuronide. The 1H
spectrum represents the sum of 2 acquisitions
while the 2H spectrum represents the sum of 5000
acquisitions for a total collection time of 2.1 h.
Spectra were acquired consecutively at 75°C with-
out lock. The numbers above the signals represent
the position of the resonating hydrogen or deute-
rium in the parent hepatic glucose-6-phosphate
molecule. Also shown is the menthol glucuronide
structure and assignments of its hydrogen NMR
signals in the 3.0- to 5.0-ppm region.
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Apart from the single hydrogen adjacent to the ether link-
age (designated Ha in Fig. 2), the signals of the menthol
moiety resonate well upfield from those of the glucuro-
nide. Also shown in Fig. 2 are 1H and 2H NMR spectra of
menthol glucuronide obtained by ether extraction of urine
following 2H2O and peppermint oil ingestion. The
1H
NMR spectrum shows well-resolved glucuronide reso-
nances with relatively little contamination from other
ether-soluble components of urine. All glucuronide proton
resonances have a corresponding 2H signal in the 2H NMR
spectrum consistent with incorporation of deuterium from
2H2O into all positions of hepatic G6P. A single additional
2H signal from an unknown metabolite is also present but
does not interfere with any of the glucuronide resonances.
The glucuronide 2H NMR signals had linewidths of
3–4 Hz: significantly broader than the typical 2H signals of
the MAG derivative (2 Hz). Nevertheless, the resonances
are sufficiently resolved to allow confident quantification
of their relative areas at 11.75 T. The T1 values of the
glucuronide 2H nuclei were not quantified but were as-
sumed to be not greater than those of MAG (i.e., 250 ms or
less).
The MG extract was then derivatized to MAG and ana-
lyzed by 1H/2H NMR in order to confirm the 2H relative
enrichment distributions derived from MG and to deter-
mine the absolute 2H enrichment values by addition of a
deuterated standard (13). The relative 2H enrichment val-
ues obtained from the 2H NMR spectrum of the glucuro-
nide were consistent with those derived from a 2H NMR
analysis of its MAG derivative (Fig. 3). Absolute 2H en-
richment values of the glucuronide moiety, as estimated
from the analysis of MAG and DMF signals, ranged from
0.11 to 0.39%. These values are consistent with recent
measurements of fasting plasma glucose 2H enrichments
following ingestion of 2H2O to 0.5% body water (6).
The gluconeogenic contribution to hepatic glucose out-
put as calculated from the glucuronide 5:2 2H-enrich-
ment ratio was estimated to be 56%, consistent with
recent MS and NMR measurements of gluconeogenesis
by the 2H2O method in overnight-fasted healthy subjects
(2,3,5,6).
DISCUSSION
We demonstrated a novel noninvasive method for quanti-
fying gluconeogenesis from 2H2O by
2H NMR analysis of
urinary menthol glucuronide. Sample processing is simple
and can be performed rapidly if needed. High-quality
spectra with a conventional 500-MHz NMR system and
broadband probe can be obtained with short collection
times. Menthol glucuronic acid is highly soluble in aceto-
nitrile and other organic solvents and is therefore compat-
ible with automated NMR systems and microprobes. More-
over, the simple 2H NMR spectrum of MG obtained after
2H2O ingestion study could potentially be processed by an
automated Bayesian analysis of the free-induction decay,
as was recently demonstrated with the MAG derivative of
plasma glucose (14). Integration of these methods could
allow the study of much larger subject populations than
was hitherto possible. However, there are some subject
groups that cannot safely tolerate the dosages of pepper-
mint oil used in this study. Peppermint oil ingestion is
contraindicated for patients with severe liver disease, gall-
bladder inflammation, or obstruction of the bile ducts. Its
effects on pregnant women or infants are not known. Ad-
ministration of peppermint oil capsules to small children
is not recommended since there is a risk of the capsule
being chewed open, resulting in irritation of the mouth
and esophagus. In a study of older children, peppermint
oil in enteric-coated capsules was given three times a day
to children 8–17 years old and weighing at least 30 kg (15).
FIG. 3. 2H NMR spectrum of monoacetone glu-
cose (65 mol) derived from menthol glucuronide.
The spectrum represents the sum of 20000 acqui-
sitions for a total collection time of 8.3 h. The
numbers above each signal represent the position
of the resonating deuterium in the parent hepatic
glucose-6-phosphate molecule. Relative 2H-en-
richments for positions 1–5 (D1–D5) of monoac-
etone glucose (MAG) and menthol glucuronide
(MG) are shown above the spectrum. In both
cases, 2H-enrichment of hydrogen 2 was arbitrarily
set to 100.
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Each dose consisted of 187–374 mg of peppermint oil (i.e.,
47–94% of the amount used in our study). No adverse
effects from the peppermint oil were reported.
Quantification of the gluconeogenic fraction of endoge-
nous glucose production from glucuronide relies on the as-
sumption that both plasma glucose and glucuronide origi-
nate from a common G6P pool and therefore have equal 2H
enrichment distributions from 2H2O. To date, this has not
been thoroughly examined in humans. In a small group of
healthy overnight-fasted subjects given 2H2O, [U-
13C]propi-
onate, and acetaminophen, glucuronide and glucose had
consistent 2H and 13C enrichment distributions (9). However,
other carbon tracer studies revealed significant differences
between glucose and glucuronide labeling, suggesting that
the two metabolites could not have originated from the same
G6P precursor pool (16).
Nonequivalent glucose and glucuronide 2H enrichment
distributions could potentially arise from the compart-
mentalization of glucose metabolism at both hepatic and
systemic levels. In the hepatic lobule, the periportal region
is considered the principal site of glucose production
while the pericentral region is the principal location for
UDP-glucose synthesis (17). Steep arteriovenous concen-
tration gradients exist for some gluconeogenic substrates,
such as glycerol, but not for others, such as lactate. This
implies that the contribution of glycerol to gluconeogene-
sis is relatively higher in the arterial periportal region
compared to pericentral and perivenous zones. In accord
with this, Ekberg et al. showed that gluconeogenic incor-
poration of [2-14C]glycerol relative to [1-14C]lactate was
higher in plasma glucose compared to glucuronide (16).
However, the extent to which changes in utilization of
individual precursor substrates modifies the total glu-
coneogenic contribution to G6P production is not known.
The contribution of glycerol to postabsorptive plasma glu-
cose production is minor (18); hence, a reduced concen-
tration of glycerol is unlikely to substantially change the
fraction of G6P derived from gluconeogenesis in pericen-
tral compared to that of periportal hepatocytes.
The liver accounts for 95% of glucuronide secretion
(19); hence, the glucuronide 2H enrichment distribution
reflects that of hepatic G6P. Fasting plasma glucose has
long been assumed to be largely derived from liver, but
recent studies have demonstrated a significant capacity for
nonhepatic glucose synthesis in humans. Gluconeogenic
carbon tracers were incorporated into plasma glucose dur-
ing the anhepatic phase of liver transplantation (20). A
functional G6P phosphohydrolase protein was identified
in several extrahepatic tissues including skeletal muscle
(21). Although this enzyme is less active than hepatic
G6P-ase, it is considered sufficiently abundant to make a
significant contribution to whole-body glucose produc-
tion. To the extent that the sources of G6P in these tissues
differ from those in liver, glucose derived from extrahe-
patic sources will have a different 2H enrichment distri-
bution compared to that of hepatic glucose.2 If there were
no exchanges between plasma glucose and intracellular
glucose of various tissues, the plasma glucose 2H enrich-
ment distribution would represent a weighted average of
hepatic and extrahepatic sources of glucose production
while the glucuronide 2H enrichment distribution
would be specific for the liver. In reality, plasma and
hepatic glucose pools are exchanged by futile cycling
between hepatic G6P and glucose via glucokinase and
G6P-ase (22). Presumably, extrahepatic tissues that pro-
duce glucose undergo a similar exchange process via a
futile cycle catalyzed by hexokinase and G6P phospho-
hydrolase. By homogenizing the various G6P pools,
these exchanges minimize any differences between glu-
cose and glucuronide 2H-enrichment distributions that
might be attributable to extrahepatic glucose produc-
tion.
In conclusion, we describe a simple method of quan-
tifying the glucuronide 2H enrichment distribution
based on the ingestion of peppermint oil and a simple
recovery of urinary menthol glucuronide. Where appli-
cable, this approach should considerably simplify the
measurement of gluconeogenesis by Landau’s 2H2O
method.
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